[go: up one dir, main page]

BR9604951A - Composição farmacêutica contendo derivados den n-fosfonoglicina par inibir o desenvolvimento de viroses e cânceres - Google Patents

Composição farmacêutica contendo derivados den n-fosfonoglicina par inibir o desenvolvimento de viroses e cânceres

Info

Publication number
BR9604951A
BR9604951A BR9604951A BR9604951A BR9604951A BR 9604951 A BR9604951 A BR 9604951A BR 9604951 A BR9604951 A BR 9604951A BR 9604951 A BR9604951 A BR 9604951A BR 9604951 A BR9604951 A BR 9604951A
Authority
BR
Brazil
Prior art keywords
cancers
viruses
inhibit
development
pharmaceutical composition
Prior art date
Application number
BR9604951A
Other languages
English (en)
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9604951A publication Critical patent/BR9604951A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9604951A 1995-04-12 1996-04-11 Composição farmacêutica contendo derivados den n-fosfonoglicina par inibir o desenvolvimento de viroses e cânceres BR9604951A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/420,940 US5665713A (en) 1995-04-12 1995-04-12 Pharmaceutical composition for inhibiting the growth of viruses and cancers
US184095P 1995-08-03 1995-08-03
PCT/US1996/004954 WO1996032115A1 (en) 1995-04-12 1996-04-11 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers

Publications (1)

Publication Number Publication Date
BR9604951A true BR9604951A (pt) 1998-06-09

Family

ID=26669550

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9604951A BR9604951A (pt) 1995-04-12 1996-04-11 Composição farmacêutica contendo derivados den n-fosfonoglicina par inibir o desenvolvimento de viroses e cânceres

Country Status (18)

Country Link
US (3) US5665713A (pt)
EP (1) EP0820291A1 (pt)
JP (1) JPH11503458A (pt)
KR (1) KR19980703830A (pt)
CN (1) CN1181014A (pt)
AR (1) AR003120A1 (pt)
AU (1) AU714057B2 (pt)
BR (1) BR9604951A (pt)
CA (1) CA2217951A1 (pt)
CZ (1) CZ323897A3 (pt)
IL (1) IL117873A (pt)
NO (1) NO974694L (pt)
NZ (1) NZ305783A (pt)
PL (1) PL322734A1 (pt)
SK (1) SK138297A3 (pt)
TR (1) TR199701148T1 (pt)
TW (1) TW457088B (pt)
WO (1) WO1996032115A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5665713A (en) * 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
DE19622355A1 (de) * 1996-06-04 1997-12-11 Bayer Ag Formkörper die agrochemische Mittel freisetzen
US5900429A (en) * 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
TR200002965T2 (tr) * 1998-04-14 2001-05-21 Jomaa,Hassan Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US7060643B2 (en) * 2000-12-28 2006-06-13 Showa Denko Kabushiki Kaisha Photo-functional powder and applications thereof
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
US20040006043A1 (en) * 2002-07-02 2004-01-08 Ramot University Authority For Applied Research & Industrial Development Ltd. Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents
MXPA05004504A (es) * 2002-10-31 2005-08-16 Metabasis Therapeutics Inc Nuevos di-esteres de fosfato ciclicos de 1,3-propano-1-aril-dioles y su uso en la preparacion de profarmacos.
EP2034828A4 (en) 2006-05-19 2011-04-06 Univ Illinois PHOSPHORUS COMPOUNDS WITH TRIPHENYL METHYL PHOSPHONATE TESTERS FOR THE TREATMENT OF MELANOMA OR OTHER TUMORS
WO2014025765A2 (en) * 2012-08-06 2014-02-13 University Of Miami Systems and methods for adaptive neural decoding
CN106061984A (zh) 2014-02-13 2016-10-26 配体药物公司 前药化合物及其用途
EP3164136A4 (en) 2014-07-02 2018-04-04 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof
JP2021509907A (ja) 2018-01-09 2021-04-08 リガンド・ファーマシューティカルズ・インコーポレイテッド アセタール化合物およびその治療的使用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3779758A (en) * 1969-03-25 1973-12-18 Photocircuits Corp Photosensitive process for producing printed circuits employing electroless deposition
US3853530A (en) * 1971-03-10 1974-12-10 Monsanto Co Regulating plants with n-phosphonomethylglycine and derivatives thereof
US3799758A (en) * 1971-08-09 1974-03-26 Monsanto Co N-phosphonomethyl-glycine phytotoxicant compositions
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
US4408052A (en) * 1980-02-27 1983-10-04 Takeda Chemical Industries, Ltd. Phospholipid carbamates
JPS5772914A (en) * 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
DE3265157D1 (en) * 1981-03-30 1985-09-12 Takeda Chemical Industries Ltd Ethyleneglycol derivatives, their production and use
US4634693A (en) * 1983-07-28 1987-01-06 Cardarelli Nathan F Tin steroids and their uses
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
JPS6081193A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd リン脂質
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten
US4866059A (en) * 1988-04-04 1989-09-12 Warner-Lambert Company '(2S)-(5-amino-1,2-dihydro-2-methyl-3-phenylpyrido(3,4-b)pyrazin-7-yl)-carbamic acid, ethyl ester
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US4994591A (en) * 1989-06-02 1991-02-19 The Research Foundation Of State University Of Ny Platinum complexes derived from b-silyamines
US5665713A (en) * 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers

Also Published As

Publication number Publication date
AU714057B2 (en) 1999-12-16
US5854231A (en) 1998-12-29
AU5389696A (en) 1996-10-30
US6090796A (en) 2000-07-18
US5665713A (en) 1997-09-09
CZ323897A3 (cs) 1998-03-18
AR003120A1 (es) 1998-07-08
TW457088B (en) 2001-10-01
IL117873A0 (en) 1996-08-04
IL117873A (en) 2001-05-20
JPH11503458A (ja) 1999-03-26
WO1996032115A1 (en) 1996-10-17
TR199701148T1 (xx) 1998-02-21
NZ305783A (en) 2001-06-29
CA2217951A1 (en) 1996-10-17
NO974694L (no) 1997-12-12
NO974694D0 (no) 1997-10-10
KR19980703830A (ko) 1998-12-05
SK138297A3 (en) 1998-05-06
EP0820291A1 (en) 1998-01-28
CN1181014A (zh) 1998-05-06
PL322734A1 (en) 1998-02-16

Similar Documents

Publication Publication Date Title
BR9604951A (pt) Composição farmacêutica contendo derivados den n-fosfonoglicina par inibir o desenvolvimento de viroses e cânceres
DZ2361A1 (fr) Dérivés de 6-phénylpyridyl-2-amine et compositionspharmaceutiques les contenant
DE69124721D1 (de) Carbostyrilderivate und diese enthaltende pharmazeutische Zusammensetzungen
ATE246490T1 (de) Pharmazeutische zusammensetzung von topiramate
PT851855E (pt) Derivados acilados de melatonina e de analogos uteis como medicamentos
DE19681727T1 (de) Kapseln/Teilchen enthaltende Shampoo-Zusammensetzung
LV11895A (lv) 4-benzoilpirazola atvasinajumi un to pielietojums par herbicidiem
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
CY2005007I1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
MX9202545A (es) Derivados biciclicos de rapamicina y composicion farmaceutica que los contiene.
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
FI943571A0 (fi) 1-bentseenisulfonyyli-1,3-dihydro-2H-bentsimidatsol-2-onijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
FI970825A (fi) Farmaseuttiset koostumukset, jotka aktiivisen yhdisteen biologisen hyötyosuuden lisäämiseksi sisältävät sappisuolaa ja puskuria
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
BR9609420A (pt) Derivados de 4-fenilaminotiazol seu processo de preparação e as composições farmacêuticas contendo os mesmos
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
BR9604950A (pt) Composição farmacêutica contendo n-clorofenil carbamatos n-clorofeniltiocarbamatos e derivados de n-fosfonoglicina para inibir o crescimento de cânceres e vírus em mamíferos
DE69603269D1 (de) Derivate von inulin
EE04015B1 (et) Asendatud 2,4-tiasolidiindiooni derivaadid, nendevalmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
KR970000228A (ko) S-에토돌락의 경구용 제제
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
HUP9901336A3 (en) Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof
FI973229A (fi) Uusi farmaseuttinen koostumus
DZ2362A1 (fr) Compositions pharmaceutiques contenant des dérivésde n-sulfonyl indoline

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law